Factors associated with the prescription of antidepressive medication to breast cancer patients

References

• Bray F, McCarron P, Parkin DM. The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res 2004;6:229–39.
   PubMed Web of Science ®Google Scholar
• Rowland JH, Hewitt M, Ganz PA. Cancer survivorship: A new challenge in delivering quality cancer care. J Clin Oncol 2006;24:5101–4.
   PubMed Web of Science ®Google Scholar
• Fann JR, Thomas-Rich AM, Katon WJ, Cowley D, Pepping M, McGregor BA, . Major depression after breast cancer: A review of epidemiology and treatment. Gen Hosp Psychiatry 2008;30:112–26.
   PubMed Web of Science ®Google Scholar
• Satin JR, Linden W, Phillips MJ. Depression as a predictor of disease progression and mortality in cancer patients: A meta-analysis. Cancer 2009;115:5349–61.
   PubMed Web of Science ®Google Scholar
• DiMatteo MR, Lepper HS, Croghan TW. Depression is a risk factor for noncompliance with medical treatment: Meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000;160:2101–7.
   PubMed Web of Science ®Google Scholar
• Fallowfield L, Ratcliffe D, Jenkins V, Saul J. Psychiatric morbidity and its recognition by doctors in patients with cancer. Br J Cancer 2001;84:1011–5.
   PubMed Web of Science ®Google Scholar
• Sharpe M, Strong V, Allen K, Rush R, Postma K, Tulloh A, . Major depression in outpatients attending a regional cancer centre: Screening and unmet treatment needs. Br J Cancer 2004;90:314–20.
   PubMed Web of Science ®Google Scholar
• Christensen S, Zachariae R, Jensen AB, Vaeth M, Møller S, Ravnsbaek J, . Prevalence and risk of depressive symptoms 3-4 months post-surgery in a nationwide cohort study of Danish women treated for early stage breast-cancer. Breast Cancer Res Treat 2009;113:339–55.
   PubMed Web of Science ®Google Scholar
• Kim SH, Son BH, Hwang SY, Han W, Yang JH, Lee S, . Fatigue and depression in disease-free breast cancer survivors: Prevalence, correlates, and association with quality of life. J Pain Symptom Manage 2008;35:644–55.
   PubMed Web of Science ®Google Scholar
• Bardwell WA, Natarajan L, Dimsdale JE, Rock CL, Mortimer JE, Hollenbach K, . Objective cancer-related variables are not associated with depressive symptoms in women treated for early-stage breast cancer. J Clin Oncol 2006;24:2420–7.
   PubMed Web of Science ®Google Scholar
• Osborne RH, Elsworth GR, Hopper JL. Age-specific norms and determinants of anxiety and depression in 731 women with breast cancer recruited through a population-based cancer registry. Eur J Cancer 2003;39:755–62.
   PubMed Web of Science ®Google Scholar
• Burgess C, Cornelius V, Love S, Graham J, Richards M, Ramirez A. Depression and anxiety in women with early breast cancer: Five year observational cohort study. BMJ 2005;330:702.
   PubMed Web of Science ®Google Scholar
• Azzone V, Frank RG, Pakes JR, Earle CC, Hassett MJ. Behavioral health services for women who have breast cancer. J Clin Oncol 2009;27:706–12.
   PubMedGoogle Scholar
• Ashbury FD, Madlensky L, Raich P, Thompson M, Whitney G, Hotz K, . Antidepressant prescribing in community cancer care. Support Care Cancer 2003;11:278–85.
   PubMed Web of Science ®Google Scholar
• Gardarsdottir H, Heerdink ER, van DL, Egberts AC. Indications for antidepressant drug prescribing in general practice in the Netherlands. J Affect Disord 2007;98:109–15.
   PubMed Web of Science ®Google Scholar
• Petty DR, House A, Knapp P, Raynor T, Zermansky A. Prevalence, duration and indications for prescribing of antidepressants in primary care. Age Ageing 2006;35:523–6.
   PubMed Web of Science ®Google Scholar
• Hoybye MT, Dalton SO, Christensen J, Larsen LR, Kuhn KG, Jensen JN, . Research in Danish cancer rehabilitation: Social characteristics and late effects of cancer among participants in the FOCARE research project. Acta Oncol 2008;47:47–55.
   PubMed Web of Science ®Google Scholar
• Moller S, Jensen MB, Ejlertsen B, Bjerre KD, Larsen M, Hansen HB, . The clinical database and the treatment guidelines of the Danish Breast Cancer Cooperative Group (DBCG); its 30-years experience and future promise. Acta Oncol 2008;47:506–24.
   PubMed Web of Science ®Google Scholar
• Thygesen L. The register-based system of demographic and social statistics in Denmark. Stat J UN Econ Comm Eur 1995;12:49–55.
   PubMedGoogle Scholar
• Nickelsen TN. Data validity and coverage in the Danish National Health Registry. A literature review. Ugeskr Laeger 2001;164:33–7. Danish.
   PubMedGoogle Scholar
• Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis 1987;40: 373–83.
   PubMedGoogle Scholar
• Gaist D, Sorensen HT, Hallas J. The Danish prescription registries. Dan Med Bull 1997;44:445–8.
   PubMed Web of Science ®Google Scholar
• Boudreau DM, Daling JR, Malone KE, Gardner JS, Blough DK, Heckbert SR. A validation study of patient interview data and pharmacy records for antihypertensive, statin, and antidepressant medication use among older women. Am J Epidemiol 2004;159:308–17.
   PubMed Web of Science ®Google Scholar
• Loprinzi CL, Wolf SL, Barton DL, Laack NN. Symptom management in premenopausal patients with breast cancer. Lancet Oncol 2008;9:993–1001.
   PubMedGoogle Scholar
• The Danish National Board of Health. [Internet]. Copenhagen (Denmark): Sundhedsstyrelsen; Kræftprofil - Brystkræft 2000–2007 [cited 2010 Mar]. Available from: http://www.sst.dk/publ/Publ2009/EPT/Kraeftprofiler/Kraeftprofil_Brystkraeft_2000-2007.pdf. Danish. 2009.
   Google Scholar